|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
5/2003
vol. 2 abstract:
Perspectives of melatonin usage in prophylaxis and treatment of postmenopausal osteoporosis
Beata Kos-Kudła
,
Bogdan Marek
,
Dariusz Kajdaniuk
,
Kinga Wołowska
,
Zofia Ostrowska
(Prz Menopauz 2003, 5: 43–46)
Online publish date: 2003/10/17
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Pathogenesis of osteoporosis is complicated, multifactorial, and is still not fully recognized. Results of below presented study suggest that among factors determining pathogenesis of this disease, not only estrogen deficiency in postmenopausal period and many other well known hormonal, growth, immunological factors but also melatonin deficiency plays a substantial role. Many of recently published studies demonstrated that increased melatonin production may have protective effect against loss of bone mass in postmenopausal period.
We postulated that administration of melatonin could have a beneficial effect in prophylaxis and treatment of postmenopausal osteoporosis. keywords:
melatonin, menopause, osteoporosis |
 |
